Atlas Trials

Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

Clinical trial NCT00128011 · COMPLETED

Trial details

NCT number
NCT00128011
Sponsor
International Vaccine Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cholera
Start date
2005-05-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.